Phase II Study of Dose-Adjusted EPOCH-Rituximab in Untreated Diffuse Large B-cell Lymphoma with Analysis of Germinal Center and Post-Germinal Center Biomarkers

PURPOSE: To assess the clinical outcome and the influence of biomarkers associated with apoptosis inhibition (Bcl-2), tumor proliferation (MIB-1) and cellular differentiation on the outcome with dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin and rituximab (DA-EPOCH-R...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Wilson, Wyndham H., Dunleavy, Kieron, Pittaluga, Stefania, Hegde, Upendra, Grant, Nicole, Steinberg, Seth M., Raffeld, Mark, Gutierrez, Martin, Chabner, Bruce A., Staudt, Louis, Jaffe, Elaine S., Janik, John E.
Формат: Artigo
Язык:Inglês
Опубликовано: 2008
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2409217/
https://ncbi.nlm.nih.gov/pubmed/18378569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.13.1391
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы